Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
NMDA Antagonists in Bipolar Depression
NCT01833897Phase 4Completed
- Sponsor
- New York State Psychiatric Institute
- Start
- Mar 2013
- Primary completion
- Jul 2014
- Modality
- Covalent Small Molecules, Classical Binding Small Molecules, Nucleic Acid-Directed Small Molecules
- Countries
- 1
01
Overview
A Phase 4 trial of d-cycloserine in bipolar disorder (BD), sponsored by New York State Psychiatric Institute. Started Mar 2013; status: completed.
02
Drugs
d-cycloserine
03
Conditions
bipolar disorder (BD)
Beyond the preview
Go deeper on NCT01833897.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01833897.